Stock listing
Alpha Cognition Inc.
- Ticker
- NASDAQ:ACOG
- Asset type
- Stock
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- NASDAQ
- Currency
- USD
About Alpha Cognition Inc.
The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.
Latest news from Alpha Cognition Inc.
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
Oct 13, 2026
Alpha Cognition: to Present New ZUNVEYL (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
Oct 6, 2026
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
Oct 1, 2026